While the aesthetic industry continues to treat symptoms, we are building the platform that regulates the underlying biological environment.
As a founder-led company, LUNARIS approaches skin recovery as a systems-level challenge—translating immune biology into scalable clinical frameworks.
Our MOON-LCR platform replaces fragmented treatments with structured recovery systems designed for professional, repeatable use.
We are not entering an existing category.
We are defining a new clinical paradigm.
Immune-regulated recovery is emerging as a key foundation of next-generation aesthetic medicine.
By positioning recovery as a structured system rather than isolated treatments, LUNARIS is building a scalable platform with strong expansion potential across inflammatory skin conditions.
